Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data.

Gozlan Y, Bucris E, Shirazi R, Rakovsky A, Ben-Ari Z, Davidov Y, Veizman E, Saadi T, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Katchman H, Menachem Y, Safadi R, Galun E, Zuckerman E, Nimer A, Hazzan R, Maor Y, Saif AM, Etzion O, Lurie Y, Mendelson E, Mor O.

Antivir Ther. 2019 Mar 18. doi: 10.3851/IMP3301. [Epub ahead of print]

PMID:
30880684
2.

Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.

Nesher E, Braun M, Eizner S, Issachar A, Cohen M, Shlomai A, Gurevich M, Tur-Kaspa R, Mor E.

Isr Med Assoc J. 2018 Dec;20(12):765-769.

3.

Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis.

Shlomai A, Leshno M, Goldstein DA.

PLoS One. 2018 Nov 8;13(11):e0207132. doi: 10.1371/journal.pone.0207132. eCollection 2018.

4.

The effect of cause, timing, kidney function recovery, and recurrent events on the prognosis of acute kidney injury in kidney transplant recipients.

van Dijk TY, Rahamimov R, Chagnac A, van Dijk DJ, Mor E, Shlomai A, Rozen-Zvi B.

Clin Transplant. 2018 Oct;32(10):e13398. doi: 10.1111/ctr.13398. Epub 2018 Sep 23.

PMID:
30175412
5.

Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.

Peleg N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, Braun M, Shlomai A.

PLoS One. 2018 Aug 14;13(8):e0202393. doi: 10.1371/journal.pone.0202393. eCollection 2018.

6.

The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities.

Shirin D, Peleg N, Sneh-Arbib O, Cohen-Naftaly M, Braun M, Shochat T, Issachar A, Shlomai A.

Dig Dis. 2019;37(1):69-76. doi: 10.1159/000491428. Epub 2018 Jul 17.

PMID:
30016799
7.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Wiessman M, Shlomai A.

N Engl J Med. 2018 Jun 28;378(26):2539. doi: 10.1056/NEJMc1805679. No abstract available.

PMID:
29952171
8.

The antiviral protein Viperin suppresses T7 promoter dependent RNA synthesis-possible implications for its antiviral activity.

Dukhovny A, Shlomai A, Sklan EH.

Sci Rep. 2018 May 25;8(1):8100. doi: 10.1038/s41598-018-26516-z.

9.

Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus.

Witt-Kehati D, Fridkin A, Alaluf MB, Zemel R, Shlomai A.

Transl Oncol. 2018 Apr;11(2):511-517. doi: 10.1016/j.tranon.2018.02.015. Epub 2018 Mar 7.

10.

Characterization of hepatitis B and delta coinfection in Israel.

Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, Shaked-Mishan P, Picard O, Shemer-Avni Y, Ben-Zvi H, Halutz O, Lurie Y, Veizman E, Carlebach M, Braun M, Naftaly MC, Shlomai A, Safadi R, Mendelson E, Sklan EH, Ben-Ari Z, Mor O.

BMC Infect Dis. 2018 Feb 27;18(1):97. doi: 10.1186/s12879-018-3008-x.

11.

A robust cell culture system supporting the complete life cycle of hepatitis B virus.

Michailidis E, Pabon J, Xiang K, Park P, Ramanan V, Hoffmann HH, Schneider WM, Bhatia SN, de Jong YP, Shlomai A, Rice CM.

Sci Rep. 2017 Nov 30;7(1):16616. doi: 10.1038/s41598-017-16882-5.

12.

AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Peleg N, Issachar A, Sneh-Arbib O, Shlomai A.

Dig Liver Dis. 2017 Oct;49(10):1133-1138. doi: 10.1016/j.dld.2017.05.002. Epub 2017 May 11.

PMID:
28572039
13.

Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?

Nesher E, Mor E, Shlomai A, Naftaly-Cohen M, Yemini R, Yussim A, Brown M, Keidar A.

Obes Surg. 2017 May;27(5):1387-1390. doi: 10.1007/s11695-017-2634-5.

PMID:
28281236
14.

HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients.

Gozlan Y, Ben-Ari Z, Moscona R, Shirazi R, Rakovsky A, Kabat A, Veizman E, Berdichevski T, Weiss P, Cohen-Ezra O, Lurie Y, Gafanovich I, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Zuckerman E, Carmiel-Haggai M, Nimer A, Hazzan R, Maor Y, Kitay-Cohen Y, Shemer-Avni Y, Kra-Oz Z, Schreiber L, Peleg O, Sierra S, Harrigan PR, Mendelson E, Mor O.

Antivir Ther. 2017;22(5):431-441. doi: 10.3851/IMP3123. Epub 2017 Jan 9.

PMID:
28067632
15.

Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.

Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A.

Dig Dis Sci. 2017 Mar;62(3):801-807. doi: 10.1007/s10620-016-4423-8. Epub 2017 Jan 4.

PMID:
28054162
16.

Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.

Hasin Y, Shteingart S, Dahari H, Gafanovich I, Floru S, Braun M, Shlomai A, Verstandig A, Dery I, Uprichard SL, Cotler SJ, Lurie Y.

World J Hepatol. 2016 Jul 18;8(20):858-62. doi: 10.4254/wjh.v8.i20.858.

17.

Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.

Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP.

J Hepatol. 2016 Aug;65(2):334-43. doi: 10.1016/j.jhep.2016.04.022. Epub 2016 May 2.

18.

A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration.

Scheel TK, Luna JM, Liniger M, Nishiuchi E, Rozen-Gagnon K, Shlomai A, Auray G, Gerber M, Fak J, Keller I, Bruggmann R, Darnell RB, Ruggli N, Rice CM.

Cell Host Microbe. 2016 Mar 9;19(3):409-23. doi: 10.1016/j.chom.2016.02.007.

19.

New therapies for chronic hepatitis B.

Bitton Alaluf M, Shlomai A.

Liver Int. 2016 Jun;36(6):775-82. doi: 10.1111/liv.13086. Epub 2016 Mar 14. Review.

PMID:
26854115
20.

Advances and Challenges in Studying Hepatitis B Virus In Vitro.

Witt-Kehati D, Bitton Alaluf M, Shlomai A.

Viruses. 2016 Jan 14;8(1). pii: E21. doi: 10.3390/v8010021. Review.

21.

Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.

March S, Ramanan V, Trehan K, Ng S, Galstian A, Gural N, Scull MA, Shlomai A, Mota MM, Fleming HE, Khetani SR, Rice CM, Bhatia SN.

Nat Protoc. 2015 Dec;10(12):2027-53. doi: 10.1038/nprot.2015.128. Epub 2015 Nov 19.

22.

Multiple liver lesions after oxaliplatin-based chemotherapy for colorectal cancer.

Shlomai A, Tobar A, Benjaminov O.

Gastroenterology. 2015 Nov;149(6):e1-3. doi: 10.1053/j.gastro.2015.02.017. Epub 2015 Oct 2. No abstract available.

PMID:
26433107
23.

Hepatitis C virus addiction to liver miR-122 takes its Toll on the host.

Shlomai A.

Hepatology. 2015 Nov;62(5):1633-5. doi: 10.1002/hep.27947. Epub 2015 Jul 25. No abstract available.

PMID:
26096908
24.

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus.

Ramanan V, Shlomai A, Cox DB, Schwartz RE, Michailidis E, Bhatta A, Scott DA, Zhang F, Rice CM, Bhatia SN.

Sci Rep. 2015 Jun 2;5:10833. doi: 10.1038/srep10833.

25.

Hepatitis B virus induces RNR-R2 expression via DNA damage response activation.

Ricardo-Lax I, Ramanan V, Michailidis E, Shamia T, Reuven N, Rice CM, Shlomai A, Shaul Y.

J Hepatol. 2015 Oct;63(4):789-96. doi: 10.1016/j.jhep.2015.05.017. Epub 2015 May 27.

PMID:
26026873
26.

Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

Shlomai A, Schwartz RE, Ramanan V, Bhatta A, de Jong YP, Bhatia SN, Rice CM.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8. doi: 10.1073/pnas.1412631111. Epub 2014 Aug 4.

27.

Virology. Getting rid of a persistent troublemaker to cure hepatitis.

Shlomai A, Rice CM.

Science. 2014 Mar 14;343(6176):1212-3. doi: 10.1126/science.1252186. No abstract available.

PMID:
24626921
28.

Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Shlomai A, de Jong YP, Rice CM.

Semin Cancer Biol. 2014 Jun;26:78-88. doi: 10.1016/j.semcancer.2014.01.004. Epub 2014 Jan 20. Review.

29.

The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1.

Adamovich Y, Shlomai A, Tsvetkov P, Umansky KB, Reuven N, Estall JL, Spiegelman BM, Shaul Y.

Mol Cell Biol. 2013 Jul;33(13):2603-13. doi: 10.1128/MCB.01672-12. Epub 2013 May 6.

30.

Role of glucose-dependent insulinotropic polypeptide in adipose tissue inflammation of dipeptidylpeptidase 4-deficient rats.

Ben-Shlomo S, Zvibel I, Varol C, Spektor L, Shlomai A, Santo EM, Halpern Z, Oren R, Fishman S.

Obesity (Silver Spring). 2013 Nov;21(11):2331-41. doi: 10.1002/oby.20340. Epub 2013 May 29.

31.

[Guidelines for diagnosis and management of cirrhotic ascites and its complications. The Israeli Association for the Study of the Liver].

Sikuler E, Ackerman Z, Braun M, Baruch Y, Bruck R, Safadi R, Shlomai A, Ben-Ari Z; Israeli Association for the Study of the Liver.

Harefuah. 2012 Dec;151(12):705-8, 719. Hebrew.

PMID:
23330265
32.

Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.

Shlomai A, Halfon P, Goldiner I, Zelber-Sagi S, Halpern Z, Oren R, Bruck R.

J Viral Hepat. 2013 Feb;20(2):95-102. doi: 10.1111/j.1365-2893.2012.01628.x. Epub 2012 Aug 3.

PMID:
23301544
33.

Targeting late SV40 factor: is the achilles heel of hepatocarcinogenesis revealed?

Shlomai A.

World J Gastroenterol. 2012 Dec 14;18(46):6709-11. doi: 10.3748/wjg.v18.i46.6709.

34.

The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.

Mouler Rechtman M, Burdelova EO, Bar-Yishay I, Ben-Yehoyada M, Fishman S, Halpern Z, Shlomai A.

J Viral Hepat. 2013 Jan;20(1):34-41. doi: 10.1111/j.1365-2893.2012.01622.x. Epub 2012 May 22.

PMID:
23231082
35.

Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis.

Ben-Shlomo S, Zvibel I, Rabinowich L, Goldiner I, Shlomai A, Santo EM, Halpern Z, Oren R, Fishman S.

Dig Dis Sci. 2013 Jan;58(1):172-8. doi: 10.1007/s10620-012-2353-7. Epub 2012 Aug 24. Erratum in: Dig Dis Sci. 2013 Feb;58(2):582. Shlomo, Shani Ben [corrected to Ben-Shlomo, Shani].

PMID:
22918684
36.

The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.

Shlomai A, Rechtman MM, Burdelova EO, Zilberberg A, Hoffman S, Solar I, Fishman S, Halpern Z, Sklan EH.

J Hepatol. 2012 Oct;57(4):867-73. doi: 10.1016/j.jhep.2012.06.021. Epub 2012 Jun 23.

PMID:
22732512
37.

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.

Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R.

J Hepatol. 2012 May;56(5):1145-51. doi: 10.1016/j.jhep.2011.12.011. Epub 2012 Jan 13.

PMID:
22245895
38.

Perinephric and epididymal fat affect hepatic metabolism in rats.

Ben-Shlomo S, Einstein FH, Zvibel I, Atias D, Shlomai A, Halpern Z, Barzilai N, Fishman S.

Obesity (Silver Spring). 2012 Jan;20(1):151-6. doi: 10.1038/oby.2011.261. Epub 2011 Aug 4.

39.

Diagnostic and prognostic value of thrombocytosis in admitted medical patients.

Tchebiner JZ, Nutman A, Boursi B, Shlomai A, Sella T, Wasserman A, Guzner-Gur H.

Am J Med Sci. 2011 Nov;342(5):395-401. doi: 10.1097/MAJ.0b013e318214768d.

PMID:
21681080
40.

Sampling variability of transient elastography according to probe location.

Zelber-Sagi S, Yeshua H, Shlomai A, Blendis L, Leshno M, Levit S, Halpern Z, Oren R.

Eur J Gastroenterol Hepatol. 2011 Jun;23(6):507-14. doi: 10.1097/MEG.0b013e328346c0f7.

PMID:
21537125
41.

Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression.

Bar-Yishay I, Shaul Y, Shlomai A.

Liver Int. 2011 Mar;31(3):282-90. doi: 10.1111/j.1478-3231.2010.02423.x. Epub 2011 Jan 11. Review.

PMID:
21281428
42.

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S.

J Hepatol. 2011 Jun;54(6):1214-23. doi: 10.1016/j.jhep.2010.09.032. Epub 2010 Oct 26.

PMID:
21145820
43.

Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome.

Shlomai A, Nutman A, Kotlovsky T, Schechner V, Carmeli Y, Guzner-Gur H.

Isr Med Assoc J. 2010 Oct;12(10):622-7.

44.

Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus.

Shlomai A, Kariv R, Leshno M, Beth-or A, Sheinberg B, Halpern Z.

J Gastroenterol Hepatol. 2010 Oct;25(10):1687-91. doi: 10.1111/j.1440-1746.2010.06369.x.

PMID:
20880180
45.

Ectopic splenomegaly.

Shlomai A, Guzner-Gur H.

Intern Med J. 2010 Aug;40(8):600. doi: 10.1111/j.1445-5994.2010.02302.x. No abstract available.

PMID:
20718886
46.

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha.

Rechtman MM, Har-Noy O, Bar-Yishay I, Fishman S, Adamovich Y, Shaul Y, Halpern Z, Shlomai A.

FEBS Lett. 2010 Jun 3;584(11):2485-90. doi: 10.1016/j.febslet.2010.04.067. Epub 2010 Apr 29. Erratum in: FEBS Lett. 2010 Jul 16;584(14):3239. Har-Noy, Ofir [added].

47.

The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector.

Shlomai A, Lubelsky Y, Har-Noy O, Shaul Y.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):619-23. doi: 10.1016/j.bbrc.2009.10.016. Epub 2009 Oct 8.

PMID:
19818740
48.

The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription.

Shlomai A, Shaul Y.

Biochem Biophys Res Commun. 2009 Apr 17;381(4):544-8. doi: 10.1016/j.bbrc.2009.02.078. Epub 2009 Feb 20.

PMID:
19233123
49.

The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon.

Shlomai A, Shaul Y.

Med Hypotheses. 2008;71(1):53-7. doi: 10.1016/j.mehy.2007.08.032. Epub 2008 Mar 10.

PMID:
18334285
50.

PGC-1alpha controls hepatitis B virus through nutritional signals.

Shlomai A, Paran N, Shaul Y.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16003-8. Epub 2006 Oct 16.

Supplemental Content

Loading ...
Support Center